Article Information
History
- May 27, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Wiebe Külper-Schiek1,†,
- Vanessa Piechotta1,†,*,
- Antonia Pilic1,
- Madeleine Batke1,
- Léa-Sophie Dreveton1,
- Brogan Geurts2,
- Judith Koch1,
- Stefan Köppe1,
- Marina Treskova1,3,
- Sabine Vygen-Bonnet1,
- Maria Waize1,
- Ole Wichmann1 and
- Thomas Harder1
- 1Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
- 2Centre for International Health Protection, Robert Koch Institute, Berlin, Germany
- 3Institute of Global Health, Heidelberg University Hospital, Heidelberg, Germany
- ↵* Corresponding author; email: piechottav{at}rki.de
↵† these authors have contributed equally to this work and share first authorship
Posted May 27, 2022.
Facing the Omicron variant – How well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review
